Your browser doesn't support javascript.
loading
Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials.
Burckhardt, Bjoern B; Ciplea, Agnes Maria; Laven, Anna; Ablonczy, László; Klingmann, Ingrid; Läer, Stephanie; Kleine, Karl; Dalinghaus, Michiel; Dukic, Milan; Breur, Johannes M P J; van der Meulen, Marijke; Swoboda, Vanessa; Schwender, Holger; Lagler, Florian B.
Afiliação
  • Burckhardt BB; Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, Düsseldorf, Germany.
  • Ciplea AM; Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, Düsseldorf, Germany.
  • Laven A; Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, Düsseldorf, Germany.
  • Ablonczy L; Pharmabrain Research and Training Center, Berlin, Germany.
  • Klingmann I; Göttsegen György Hungarian Institute of Cardiology, Budapest, Hungary.
  • Läer S; Pharmaplex Ba, Wezembeek-Opperm, Belgium.
  • Kleine K; Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University, Düsseldorf, Germany.
  • Dalinghaus M; Simply Quality-Dr. Karl Kleine, Weilheim in Oberbayern, Germany.
  • Dukic M; Erasmus MC, Sophia Children's Hospital, Rotterdam, Netherlands.
  • Breur JMPJ; University of Belgrade, Medical School, Belgrade, Serbia.
  • van der Meulen M; University Medical Center, Wilhelmina Children's Hospital, Utrecht, Netherlands.
  • Swoboda V; Erasmus MC, Sophia Children's Hospital, Rotterdam, Netherlands.
  • Schwender H; Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Lagler FB; Mathematical Institute, Heinrich Heine University, Düsseldorf, Germany.
Front Pharmacol ; 11: 603042, 2020.
Article em En | MEDLINE | ID: mdl-33424611
ABSTRACT

Background:

Pediatric trials to add missing data for evidence-based pharmacotherapy are still scarce. A tailored training concept appears to be a promising tool to cope with critical and complex situations before enrolling the very first patient and subsequently to ensure high-quality study conduct. The aim was to facilitate study success by optimizing the preparedness of the study staff shift.

Method:

An interdisciplinary faculty developed a simulation training focusing on the communication within the informed consent procedure and the conduct of the complex pharmacokinetic/pharmacodynamic (PK/PD) sampling within a simulation facility. Scenarios were video-debriefed by an audio-video system and manikins with artificial blood simulating patients were used. The training was evaluated by participants' self-assessment before and during trial recruitment.

Results:

The simulation training identified different optimization potentials for improved informed consent process and study conduct. It facilitated the reduction of avoidable errors, especially in the early phase of a clinical study. The knowledge gained through the intervention was used to train the study teams, improve the team composition and optimize the on-ward setting for the FP-7 funded "LENA" project (grant agreement no. 602295). Self-perceived ability to communicate core elements of the trial as well as its correct performance of sample preparation increased significantly (mean, 95% CI, p ≤ 0.0001) from 3 (2.5-3.5) to four points (4.0-4.5), and from 2 (1.5-2.5) to five points (4.0-5.0).

Conclusion:

An innovative training concept to optimize the informed consent process and study conduct was successfully developed and enabled high-quality conduct of the pediatric trials as of the very first patient visit.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha